Pulished Date August, 2019
ID: 64
Share on
Share on

Asia Pacific Veterinary Vaccines Market Analysis - By Type (Livestock Vaccines & Companion Vaccines), By Technology (Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, Toxoid Vaccines, Subunit Vaccines, DNA Vaccines & Conjugate Vaccines) & By Country (India, China, South Korea, Australia, Japan & Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends, Forecast | 2019 - 2024

Pulished: August, 2019
ID: 64
Pages: 135

APAC Veterinary Vaccines Market Size & Growth Rate (2019 - 2024)

The Asia-Pacific animal vaccines market is poised to reach USD 1.53 Billion by 2024 from USD 1.08 Billion in 2019, at a CAGR of 7.22% from 2019 - 2024  and considered as the fastest-growing region in the global veterinary vaccines market

It has seen significant growth over the past few years, due to fear of imminent epidemics that have led to substantial losses, particularly in the poultry segment. The veterinary vaccine market’s substantial growth can be attributed to increasing husbandry practices and better management of farms. This marks the estimation of further growth in the market due to the advancement in biotechnological research.

The major growth opportunity for the market is the increasing adoption of pet animals and also the rise in the number of pet lovers. Veterinary vaccines play important role in preventing infectious diseases in animals and this factor is boosting up the demand of the market extensively. In the Asia Pacific, there are increasing incidences of zoonotic diseases where government agencies are taking initial steps in order to control the spread of diseases is fuelling the growth of the market.

In addition, increasing the livestock population is one more factor lavishing the growth of the market. Increasing investments in veterinary hospitals to improve the quality of treatment procedures at low cost is creating chances for the market to grow. Growing demand to increase the productivity of poultry products with great quality is merely to lavish the demand of this market in Asia pacific. The rise in the consumption rate of meat is gearing up the growth of the market. Increasing campaigns to spread awareness in rural areas and to prevent transmission of diseases from animals to humans is spurring the growth of the veterinary vaccines market.

This research report segmented and sub-segmented into the following categories:

By Type: Livestock Vaccines and Companion Vaccines

By Technology: Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, Toxoid Vaccines, Subunit Vaccines, DNA Vaccines, and Conjugate Vaccines

By Country: India, China, Japan, Australia, South Korea and Rest of Asia Pacific

Among all, India is holding the highest shares of the market. Rising carious diseases in livestock are bolstering the demand of the market eventually. Also, growing awareness over the availability of different vaccines for various diseases is likely to magnify the demand of the market.

China is also accounted to have significant shares of the market following India. Increasing revenue is one of the best parts for China to have leading shares in this market. A rise in the adoption of companion animals is boosting up the growth rate of the market.

Japan is witnessed in having the fastest growth rate form the past few years and is also expected to have the same growth flow in the coming years. Shifting to DNA vaccines rather than live attenuated vaccines will increase the performance levels in controlling the diseases and this is majorly considered as a growth factor for the market. Also, Adoption of recombinant vaccine solutions is fuelling the growth rate of the market in this country.

Australia is anticipated to have inclined growth rates in the coming years with rising awareness towards safety measurements for animal healthcare.

South Korea is deemed to have significant shares in the coming years by increasing investments from private and public organizations.

Prominent companies playing an active role in the Asia-Pacific Veterinary Vaccines Market are:

  1. Bayer HealthCare AG
  2. Bioniche Animal Health Canada
  3. Sanofi Animal Health. Inc
  4. Biogenesis Bago SA
  5. Heska Corporation,
  6. Indian Immunologicals Ltd.
  7. Boehringer Ingelheim GmbH
  8. Zoetis, Novartis Animal Health. Inc
  9. Merck & Co. Inc
  10. Protein Sciences
  1. Introduction

                1.1 Market Definition                                                                    

                1.2 Study Deliverables                                                                  

                1.3 Base Currency, Base Year and Forecast Periods

                1.4 General Study Assumptions                                                                

  1. Research Methodology

                2.1 Introduction                                                                               

                2.2 Analysis Design                                                                         

                2.3 Research Phases                                                                      

                                2.3.1 Secondary Research                                                           

                                2.3.2 Primary Research                                                 

                                2.3.3 Econometric Modelling                                                      

                                2.3.4 Expert Validation                                                  

                2.4 Study Timeline                                                                          

  1. Overview

                3.1 Executive Summary                                                                

                3.2 Key Inferences                                                                         

                3.3 New Developments                                                               

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                                                          

                4.2 Market Restraints                                                                    

                4.3 Key Challenges                                                                         

                4.4 Current Opportunities in the Market                                                                              

  1. Market Segmentation

                5.1 By Type                                                                        

                                5.1.1 Livestock vaccines                                                

                                                5.1.1.1 Bovine                                   

                                                5.1.1.2 Porcine                                 

                                                5.1.1.3 Ovine                                     

                                                5.1.1.4 Poultry                                  

                                                5.1.1.5 Equine                                   

                                5.1.2 Companion vaccines                                                           

                                                5.1.2.1 Canine                                   

                                                5.1.2.2 Feline                                    

                5.2 Technology                                                                 

                                5.2.1 Live attenuated vaccines                                                  

                                5.2.2 Inactivated vaccines                                                            

                                5.2.3 Recombinant vaccines                                                       

                                5.2.4 Toxoid vaccines                                                     

                                5.2.5 Subunit vaccines                                                   

                                5.2.6 DNA vaccines                                                         

                                5.2.7 Conjugate vaccines                                                             

  1. Geographical Analysis

                6.1 Introduction                                                                               

                6.2 China                                                                             

                6.3 India                                                                              

                6.4 Japan                                                                            

                6.5 South Korea                                                                               

  1. Strategic Analysis

                7.1 PESTLE analysis                                                                         

                                7.1.1 Political                                                     

                                7.1.2 Economic                                                 

                                7.1.3 Social                                                         

                                7.1.4 Technological                                                         

                                7.1.5 Legal                                                          

                                7.1.6 Environmental                                                       

                7.2 Porter’s Five analysis                                                                              

                                7.2.1 Bargaining Power of Suppliers                                                        

                                7.2.2 Bargaining Power of Consumers                                                    

                                7.2.3 Threat of New Entrants                                                     

                                7.2.4 Threat of Substitute Products and Services                                                              

                                7.2.5 Competitive Rivalry within the Industry                                                     

  1. Market Leaders' Analysis

                8.1 Bayer Healthcare AG                                                                              

                                8.1.1 Overview                                                 

                                8.1.2 Product Analysis                                                   

                                8.1.3 Strategic Evaluation and Operations                                                            

                                8.1.4 Financial analysis                                                  

                                8.1.5 Legal issues                                                             

                                8.1.6 Recent Developments                                                       

                                8.1.7 SWOT analysis                                                       

                                8.1.8 Analyst View                                                          

                8.2 Bioniche Animal Health Canada                                                                         

                8.3 Sanofi Animal Health Inc.                                                                      

                8.4 Biogenesis Bago SA                                                                 

                8.5 Heska Corporation                                                                  

                8.6 Indian Immunologicals Ltd.                                                                  

                8.7 Boehringer Ingelheim GmbH                                                                              

                8.8 Novartis Animal Health, Inc.                                                                

                8.9 Merck & Co. Inc.                                                                       

                8.10 Protein Sciences                                                                    

  1. Competitive Landscape

                9.1 Market share analysis                                                                            

                9.2 Merger and Acquisition Analysis                                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                                         

                9.4 New Product Launches                                                                         

  1. Expert Opinions

                10.1 Market Outlook                                                                     

                10.2 Investment Opportunities                                                                 

     Appendix                                                                                          

  1. List of Tables
  2. List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Veterinary Vaccines Market By Region, From 2019 - 2024 ( USD Billion )
  2. Asia-Pacific Veterinary Vaccines Market By Type, From 2019 - 2024 ( USD Billion )
  3. Asia-Pacific Livestock vaccines Market By Region, From 2019 - 2024 ( USD Billion )
  4. Asia-Pacific Companion vaccines Market By Region, From 2019 - 2024 ( USD Billion )
  5. Asia-Pacific Veterinary Vaccines Market By Technology, From 2019 - 2024 ( USD Billion )
  6. Asia-Pacific Live attenuated vaccines Market By Region, From 2019 - 2024 ( USD Billion )
  7. Asia-Pacific Inactivated vaccines Market By Region, From 2019 - 2024 ( USD Billion )
  8. Asia-Pacific Recombinant vaccines Market By Region, From 2019 - 2024 ( USD Billion )
  9. Asia-Pacific Toxoid vaccines Market By Region, From 2019 - 2024 ( USD Billion )
  10. Asia-Pacific Subunit vaccines Market By Region, From 2019 - 2024 ( USD Billion )
  11. Asia-Pacific DNA vaccines Market By Region, From 2019 - 2024 ( USD Billion )
  12. Asia-Pacific Conjugate vaccines Market By Region, From 2019 - 2024 ( USD Billion )
  13. Asia-Pacific Livestock Vaccines Market By Type, From 2019 - 2024 ( USD Billion )
  14. Asia-Pacific Bovine Market By Region, From 2019 - 2024 ( USD Billion )
  15. Asia-Pacific porcine Market By Region, From 2019 - 2024 ( USD Billion )
  16. Asia-Pacific Ovine Market By Region, From 2019 - 2024 ( USD Billion )
  17. Asia-Pacific Poultry Market By Region, From 2019 - 2024 ( USD Billion )
  18. Asia-Pacific Equine Market By Region, From 2019 - 2024 ( USD Billion )
  19. Asia-Pacific Companion Animal Vaccines Market By Type, From 2019 - 2024 ( USD Billion )
  20. Asia-Pacific canine Market By Region, From 2019 - 2024 ( USD Billion )
  21. Asia-Pacific feline Market By Region, From 2019 - 2024 ( USD Billion )
  22. China Veterinary Vaccines Market By Type, From 2019 - 2024 ( USD Billion )
  23. China Veterinary Vaccines Market By Technology, From 2019 - 2024 ( USD Billion )
  24. India Veterinary Vaccines Market By Type, From 2019 - 2024 ( USD Billion )
  25. India Veterinary Vaccines Market By Technology, From 2019 - 2024 ( USD Billion )
  26. Japan Veterinary Vaccines Market By Type, From 2019 - 2024 ( USD Billion )
  27. Japan Veterinary Vaccines Market By Technology, From 2019 - 2024 ( USD Billion )
  28. South Korea Veterinary Vaccines Market By Type, From 2019 - 2024 ( USD Billion )
  29. South Korea Veterinary Vaccines Market By Technology, From 2019 - 2024 ( USD Billion )
  30. China Livestock Vaccines Market By Type, From 2019 - 2024 ( USD Billion )
  31. India Livestock Vaccines Market By Type, From 2019 - 2024 ( USD Billion )
  32. Japan Livestock Vaccines Market By Type, From 2019 - 2024 ( USD Billion )
  33. South Korea Livestock Vaccines Market By Type, From 2019 - 2024 ( USD Billion )
  34. China Companion Animal Vaccines Market By Type, From 2019 - 2024 ( USD Billion )
  35. India Companion Animal Vaccines Market By Type, From 2019 - 2024 ( USD Billion )
  36. Japan Companion Animal Vaccines Market By Type, From 2019 - 2024 ( USD Billion )
  37. South Korea Companion Animal Vaccines Market By Type, From 2019 - 2024 ( USD Billion )

Please wait. . . . Your request is being processed

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample